Terms: = Endocrine gland cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130 AND Treatment
23 results:
1. Butein Inhibits Cell Growth by Blocking the IL-6/IL-6Rα Interaction in Human Ovarian cancer and by Regulation of the IL-6/STAT3/FoxO3a Pathway.
Park SA; Seo YJ; Kim LK; Kim HJ; Yoon KD; Heo TH
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047012
[No Abstract] [Full Text] [Related]
2. Inhibition of gp130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer.
Park SA; Kim LK; Park HM; Kim HJ; Heo TH
Oncol Rep; 2022 Mar; 47(3):. PubMed ID: 35029286
[TBL] [Abstract] [Full Text] [Related]
3. Oncostatin M Receptor-Targeted Antibodies Suppress STAT3 Signaling and Inhibit Ovarian cancer Growth.
Geethadevi A; Nair A; Parashar D; Ku Z; Xiong W; Deng H; Li Y; George J; McAllister DM; Sun Y; Kadamberi IP; Gupta P; Dwinell MB; Bradley WH; Rader JS; Rui H; Schwabe RF; Zhang N; Pradeep S; An Z; Chaluvally-Raghavan P
Cancer Res; 2021 Oct; 81(20):5336-5352. PubMed ID: 34380633
[TBL] [Abstract] [Full Text] [Related]
4. Therapeutic targeting of STAT3 pathways in pancreatic adenocarcinoma: A systematic review of clinical and preclinical literature.
Peisl S; Mellenthin C; Vignot L; Gonelle-Gispert C; Bühler L; Egger B
PLoS One; 2021; 16(6):e0252397. PubMed ID: 34138876
[TBL] [Abstract] [Full Text] [Related]
5. TLR4/IL-6/IRF1 signaling regulates androgen receptor expression: A potential therapeutic target to overcome taxol resistance in ovarian cancer.
Huang SL; Chang TC; Chao CCK; Sun NK
Biochem Pharmacol; 2021 Apr; 186():114456. PubMed ID: 33556340
[TBL] [Abstract] [Full Text] [Related]
6. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
[TBL] [Abstract] [Full Text] [Related]
7. Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218.
Alvarez Secord A; Bell Burdett K; Owzar K; Tritchler D; Sibley AB; Liu Y; Starr MD; Brady JC; Lankes HA; Hurwitz HI; Mannel RS; Tewari KS; O'Malley DM; Gray H; Bakkum-Gamez JN; Fujiwara K; Boente M; Deng W; Burger RA; Birrer MJ; Nixon AB
Clin Cancer Res; 2020 Mar; 26(6):1288-1296. PubMed ID: 31919136
[TBL] [Abstract] [Full Text] [Related]
8. Effect of preoperative computed tomography parameters and obesity on surgical outcomes of laparoendoscopic single-site adrenalectomy.
Chen YC; Lee HY; Shih MP; Juan YS; Chen HW; Wu WJ; Wang YT; Li CC
Surg Endosc; 2020 Nov; 34(11):4781-4787. PubMed ID: 31792689
[TBL] [Abstract] [Full Text] [Related]
9. Broadening horizons with
Ballal S; Yadav MP; Bal C; Sahoo RK; Tripathi M
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):934-946. PubMed ID: 31707430
[TBL] [Abstract] [Full Text] [Related]
10. treatment OF TOXIC THYROID ADENOMA BY THE ETHANOL DESTRUCTION METHOD.
Espenbetova M; Zhumanbayeva Z; Krykpayeva A; Amrenova K; Glushkova N
Georgian Med News; 2018 Mar; (276):81-86. PubMed ID: 29697387
[TBL] [Abstract] [Full Text] [Related]
11. Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival.
Wörmann SM; Song L; Ai J; Diakopoulos KN; Kurkowski MU; Görgülü K; Ruess D; Campbell A; Doglioni C; Jodrell D; Neesse A; Demir IE; Karpathaki AP; Barenboim M; Hagemann T; Rose-John S; Sansom O; Schmid RM; Protti MP; Lesina M; Algül H
Gastroenterology; 2016 Jul; 151(1):180-193.e12. PubMed ID: 27003603
[TBL] [Abstract] [Full Text] [Related]
12. Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing.
Takenaka M; Saito M; Iwakawa R; Yanaihara N; Saito M; Kato M; Ichikawa H; Shibata T; Yokota J; Okamoto A; Kohno T
Int J Oncol; 2015; 46(6):2389-98. PubMed ID: 25846456
[TBL] [Abstract] [Full Text] [Related]
13. α-Mangostin: a dietary antioxidant derived from the pericarp of Garcinia mangostana L. inhibits pancreatic tumor growth in xenograft mouse model.
Hafeez BB; Mustafa A; Fischer JW; Singh A; Zhong W; Shekhani MO; Meske L; Havighurst T; Kim K; Verma AK
Antioxid Redox Signal; 2014 Aug; 21(5):682-99. PubMed ID: 24295217
[TBL] [Abstract] [Full Text] [Related]
14. Clinical significance of coagulation assays in metastatic pancreatic adenocarcinoma.
Tas F; Karabulut S; Bilgin E; Kılıc L; Ciftci R; Duranyildiz D
J Gastrointest Cancer; 2013 Dec; 44(4):404-9. PubMed ID: 23765155
[TBL] [Abstract] [Full Text] [Related]
15. Minocycline suppresses interleukine-6, its receptor system and signaling pathways and impairs migration, invasion and adhesion capacity of ovarian cancer cells: in vitro and in vivo studies.
Ataie-Kachoie P; Morris DL; Pourgholami MH
PLoS One; 2013; 8(4):e60817. PubMed ID: 23593315
[TBL] [Abstract] [Full Text] [Related]
16. Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer.
Xu S; Grande F; Garofalo A; Neamati N
Mol Cancer Ther; 2013 Jun; 12(6):937-49. PubMed ID: 23536726
[TBL] [Abstract] [Full Text] [Related]
17. Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells.
Wang Y; Li L; Guo X; Jin X; Sun W; Zhang X; Xu RC
Cytokine; 2012 Aug; 59(2):228-36. PubMed ID: 22595649
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistochemical evaluation of inflammatory and proliferative markers in adjacent normal thyroid tissue in patients undergoing total thyroidectomy: results of a preliminary study.
Ardito G; Revelli L; Boninsegna A; Sgambato A; Moschella F; Marzola MC; Giustozzi E; Avenia N; Castelli M; Rubello D
J Exp Clin Cancer Res; 2010 Jun; 29(1):77. PubMed ID: 20565793
[TBL] [Abstract] [Full Text] [Related]
19. Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer.
Landen CN; Lin YG; Armaiz Pena GN; Das PD; Arevalo JM; Kamat AA; Han LY; Jennings NB; Spannuth WA; Thaker PH; Lutgendorf SK; Savary CA; Sanguino AM; Lopez-Berestein G; Cole SW; Sood AK
Cancer Res; 2007 Nov; 67(21):10389-96. PubMed ID: 17974982
[TBL] [Abstract] [Full Text] [Related]
20. Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells.
Park JI; Strock CJ; Ball DW; Nelkin BD
Cytokine; 2005 Feb; 29(3):125-34. PubMed ID: 15613280
[TBL] [Abstract] [Full Text] [Related]
[Next]
